Experimental models and preclinical studies show beneficial effects of GLP-1R agonism on Alzheimer’s disease’s neuropathological features, including cholinergic basal forebrain nuclei degeneration and cognition [40,41,42]. Here, GLP1R is linked to early-onset autosomal dominant Alzheimer disease.